Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
复制标题
DOI：
10.1016/s0197-2456(00)00095-7
复制
发表时间：
2000-12-01
期刊：
影响因子：
--
通讯作者：
Weissfeld, JL
中科院分区：
文献类型：
--
作者：
Miller, AB;Yurgalevitch, S;Weissfeld, JL
在前列腺、肺、结直肠和卵巢（PLCO）癌症筛查试验中采用的程序被描述。这些程序旨在确保对所有确诊或疑似PLCO癌症的潜在死亡原因作出公正的决定。任命了一个死亡审查委员会，由一名无投票权的主席和三名经验丰富的审查人员担任成员。经过初步的试点研究后，这些程序已经制订，并且运作良好。对照临床试验2000；21:400 - 406s (C) Elsevier Science Inc. 2000。
The procedures that have been adopted in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial are described. These procedures have been designed to ensure unbiased decisions on the underlying cause of death for all confirmed or suspected PLCO cancers. A death review committee with a nonvoting chair and three experienced reviewers as members has been appointed. After an initial pilot study, the procedures have been instituted and are working well. Control Clin Trials 2000;21:400S-406S (C) Elsevier Science Inc. 2000.